Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-14

Clinical Trial Update: STUDY02001740;22SCH740: Estradiol For ER+ Advanced Breast Cancer (ESTHER) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating estradiol for ER-positive advanced/metastatic breast cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ESTRADIOL (Estradiol)

Snippet

Sponsor: Dartmouth-Hitchcock Medical Center | Conditions: Metastatic Breast Cancer | Phase 2 | Status: RECRUITING